Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic function
Wandena S Siegel-Lakhai, Mirjam Crul, Peter De Porre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2003
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
Vic J Verwaal, Serge van Ruth, Eeclo de Bree, et al.
Oncology Reports
|
June 2, 2010
Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry
Helgi H Helgason, Judith Y M Engwegen, Marc Zapatka, et al.
Clinical Nuclear Medicine
|
August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer
Jurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Annals of Surgical Oncology
|
December 6, 2013
The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy
Jurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Endoscopy
|
October 1, 2014
A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia
Daisy Walter, Maarten W van den Berg, Jeanin E van Hooft, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 24, 2015
Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study
Anouk K Trip, Jurriën Stiekema, Otto Visser, et al.
Diseases of the Colon and Rectum
|
April 7, 2017
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Wijntje J van Eden, Niels F Kok, Katarzyna Jóźwiak, et al.
Cancer Cytopathology
|
February 16, 2017
Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer
Anna Stiekema, Koen K Van de Vijver, Henk Boot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
Isa E L M Kuppens, Eric Dansin, Henk Boot, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic function
Wandena S Siegel-Lakhai, Mirjam Crul, Peter De Porre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 2003
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
Vic J Verwaal, Serge van Ruth, Eeclo de Bree, et al.
Oncology Reports
|
June 2, 2010
Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry
Helgi H Helgason, Judith Y M Engwegen, Marc Zapatka, et al.
Clinical Nuclear Medicine
|
August 21, 2014
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer
Jurriën Stiekema, Daan Vermeulen, Erik Vegt, et al.
Annals of Surgical Oncology
|
December 6, 2013
The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy
Jurriën Stiekema, Anouk K Trip, Edwin P M Jansen, et al.
Endoscopy
|
October 1, 2014
A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia
Daisy Walter, Maarten W van den Berg, Jeanin E van Hooft, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 24, 2015
Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study
Anouk K Trip, Jurriën Stiekema, Otto Visser, et al.
Diseases of the Colon and Rectum
|
April 7, 2017
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Wijntje J van Eden, Niels F Kok, Katarzyna Jóźwiak, et al.
Cancer Cytopathology
|
February 16, 2017
Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer
Anna Stiekema, Koen K Van de Vijver, Henk Boot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
Isa E L M Kuppens, Eric Dansin, Henk Boot, et al.
Page
of 6